DaVita Inc. (NYSE:DVA) Shares Acquired by GAMMA Investing LLC

GAMMA Investing LLC increased its position in DaVita Inc. (NYSE:DVA) by 20.7% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,587 shares of the company’s stock after purchasing an additional 272 shares during the period. GAMMA Investing LLC’s holdings in DaVita were worth $237,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Franklin Resources Inc. grew its position in shares of DaVita by 134.6% in the 3rd quarter. Franklin Resources Inc. now owns 54,901 shares of the company’s stock worth $8,885,000 after acquiring an additional 31,502 shares in the last quarter. FMR LLC increased its stake in DaVita by 659.9% during the third quarter. FMR LLC now owns 177,406 shares of the company’s stock valued at $29,082,000 after purchasing an additional 154,061 shares during the last quarter. Atom Investors LP acquired a new stake in shares of DaVita during the third quarter worth $4,094,000. Neo Ivy Capital Management bought a new position in shares of DaVita in the 3rd quarter worth about $726,000. Finally, Quest Partners LLC acquired a new position in shares of DaVita in the 3rd quarter valued at about $669,000. 90.12% of the stock is owned by institutional investors.

DaVita Trading Up 0.8 %

Shares of DVA stock opened at $152.73 on Wednesday. The firm has a market capitalization of $12.52 billion, a PE ratio of 16.48, a price-to-earnings-growth ratio of 0.86 and a beta of 0.92. The company has a debt-to-equity ratio of 15.78, a quick ratio of 1.33 and a current ratio of 1.37. DaVita Inc. has a 1 year low of $103.40 and a 1 year high of $169.51. The stock has a fifty day moving average of $154.88 and a two-hundred day moving average of $151.87.

DaVita (NYSE:DVA) last announced its earnings results on Tuesday, October 29th. The company reported $2.59 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.76 by ($0.17). DaVita had a net margin of 6.53% and a return on equity of 88.18%. The company had revenue of $3.26 billion during the quarter, compared to the consensus estimate of $3.25 billion. During the same quarter in the prior year, the company earned $2.85 EPS. The business’s quarterly revenue was up 4.6% on a year-over-year basis. As a group, research analysts expect that DaVita Inc. will post 9.71 EPS for the current year.

Analyst Ratings Changes

DVA has been the topic of a number of recent research reports. Truist Financial raised their target price on shares of DaVita from $165.00 to $175.00 and gave the stock a “hold” rating in a report on Monday, October 7th. Barclays increased their target price on DaVita from $150.00 to $164.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 31st. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, DaVita presently has an average rating of “Hold” and an average price target of $161.80.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.